Biocom California's 16th Annual Global Life Science Partnering & Investor Conference is an exclusive global partnering and networking forum that brings together over 500 investors and senior executives, including CEOs and heads of...
Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest...
This is your chance to learn strategies on how to mitigate geopolitical risks and navigate the technical complexities of reshoring your supply chain. This session provides a strategic roadmap for...
Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest...
Electronic consent (eConsent) systems have proven to add value to patients, sponsors, and sites. However, varying regulations across regions and countries can impact implementation of eConsent solutions and dilute the...
While platform approaches can effectively expedite standard programs, innovators often confront molecules with unique challenges and unanticipated technical hurdles. These programs require a team that has not only the technical...
The Demy-Colton Executive Clinics, part of the Global Biotech CEO Summit family of conferences, are designed to advance the capabilities of current and future life science executives. These intensive, one-day...
Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest...
The current oligo manufacturing paradigm relies on solid-phase synthesis, a process heavily reliant on organic solvents/raw materials. However, siRNA manufacturers—both biotechs and CDMOs—are in the process of starting a slow...
This premier conference brings together newly public and select private biotech companies with the investment banking community for two days of business and regulatory sessions, Company Presentations, BIO Partnering™, and...
Transform your CGT manufacturing from a regulatory bottleneck into a competitive powerhouse. Learn how digital integration slashes release times and harmonizes FDA/EMA compliance. You’ll walk away with a clear roadmap...
The draft ICH Q1 guidance marks a major shift in biologics stability, turning it from a back-end regulatory task into a front-line, risk-based development discipline. This session explores why traditional...
